Atopic Dermatitis (Eczema) clinical trials at UC Irvine
4 in progress, 1 open to eligible people
Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)
open to eligible people ages 12-100
The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.
Orange, California and other locations
Rocatinlimab in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)
Sorry, in progress, not accepting new patients
The primary objective of this study is to describe the safety and tolerability of rocatinlimab in adolescents with moderate-to-severe AD.
Irvine, California and other locations
Upadacitinib in Adolescents and Adults With Moderate to Severe Atopic Dermatitis (Measure Up 2)
Sorry, in progress, not accepting new patients
The objective of this study is to assess the efficacy and safety of upadacitinib for the treatment of adolescent and adult participants with moderate to severe atopic dermatitis (AD) who are candidates for systemic therapy.
Irvine, California and other locations
Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis
Sorry, accepting new patients by invitation only
The objective of this study is to assess the efficacy and safety of upadacitinib combined with topical corticosteroids (TCS) for the treatment of adolescent and adult participants with moderate to severe atopic dermatitis (AD) who are candidates for systemic therapy.
Irvine, California and other locations
Last updated: